REXTOVY
Amphastar Pharmaceuticals, Inc.
Mark For: REXTOVY™ trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 97820173 |
| Mark Literal Elements | REXTOVY |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | Trademark, Service Mark |
| Current Location | PUBLICATION AND ISSUE SECTION 2024-02-13 |
| Basis | 1(b) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Bethany J. Whelan |
| Attorney Docket Number | AMPHA-141-TM |
Timeline
| 2023-03-02 | Application Filed |
| 2023-03-06 | Location: NEW APPLICATION PROCESSING |
| 2023-03-06 | Status: Live/Pending |
| 2023-03-06 | Transaction Date |
| 2023-07-18 | Published |
| 2024-02-13 | Location: PUBLICATION AND ISSUE SECTION |
| 2024-02-13 | Status: Application has been published for opposition. The opposition period begins on the date of publication. |
Trademark Parties (Applicants & Owners)
| Party: |  AMPHASTAR PHARMACEUTICALS, INC. |
| Address | 11570 Sixth Street Rancho Cucamonga, CALIFORNIA UNITED STATES 91730 |
| Legal Entity Type | Corporation |
| Legal Entity State | DELAWARE |
Documents
 Application | 2023-03-02 | |
| Drawing | 2023-03-02 | |
| XSearch Search Summary | 2023-05-15 | |
| TRAM Snapshot of App at Pub for Oppostn | 2023-05-16 | |
| Examiner's Amendment | 2023-06-09 | |
| Amendment and Mail Process Complete | 2023-06-10 | |
| TRAM Snapshot of App at Pub for Oppostn | 2023-06-10 | |
| Notice of Publication | 2023-06-28 | |
| Notification Of Notice of Publication | 2023-06-28 | |
| OG Publication Confirmation | 2023-07-18 | |
| Post Publication Amendment | 2024-01-11 | |
| Amendment and Mail Process Complete | 2024-02-14 |
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations, namely, opioid antagonists and narcotic antagonists; pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose; Intranasal drug delivery devices, injector devices for nasal delivery, or devices for nasal delivery, all pre-filled with pharmaceuticals, namely, opioid antagonists and narcotic antagonists and pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose; nasal spray preparations |
Assignments
| Description | Date |
|---|---|
 Trademark Assignment 8118-0671 [7 Pages] | 2023-06-30 |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED | 2024-02-13 | |
| ASSIGNED TO PETITION STAFF | 2024-02-12 | |
| EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | 2024-01-25 | |
| TEAS POST PUBLICATION AMENDMENT RECEIVED | 2024-01-11 | |
| EXTENSION OF TIME TO OPPOSE RECEIVED | 2023-08-10 | |
| PUBLISHED FOR OPPOSITION | 2023-07-18 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2023-07-18 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2023-06-28 | |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2023-06-09 | |
| EXAMINERS AMENDMENT E-MAILED | 2023-06-09 | |
| EXAMINERS AMENDMENT -WRITTEN | 2023-06-09 | |
| EXAMINER'S AMENDMENT ENTERED | 2023-06-09 | |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2023-06-09 | |
| PREVIOUS ALLOWANCE COUNT WITHDRAWN | 2023-06-05 | |
| WITHDRAWN FROM PUB - OG REVIEW QUERY | 2023-05-30 | |
| ASSIGNED TO EXAMINER | 2023-05-15 | |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2023-05-15 | |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2023-03-22 | |
| NEW APPLICATION ENTERED | 2023-03-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 